Plasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis.
A critical link between hemostatic factors and atherosclerosis has been inferred from a variety of indirect observations, including the expression of procoagulant and fibrinolytic factors within atherosclerotic vessels, the presence of fibrin in intimal lesions, and the cellular infiltration of mural thrombi leading to their incorporation into developing plaques. To directly examine the role of the key fibrinolytic factor, plasminogen, in atherogenesis, plasminogen-deficient mice were crossed to hypercholesterolemic, apolipoprotein E-deficient mice predisposed to atherosclerosis. We report that the loss of plasminogen greatly accelerates the formation of intimal lesions in apolipoprotein E-deficient animals, whereas plasminogen deficiency alone does not cause appreciable atherosclerosis. These studies provide direct evidence that circulating hemostatic factors strongly influence vessel wall disease in the context of a disorder in lipid metabolism.
Xiao
Q
Q
Division of Developmental Biology, Children's Hospital Research Foundation, Cincinnati, OH 45229, USA.
Danton
M J
MJ
Witte
D P
DP
Kowala
M C
MC
Valentine
M T
MT
Bugge
T H
TH
Degen
J L
JL
D000818:Animals; D001013:Aorta, Thoracic / Q000473:pathology; D001057:Apolipoproteins E / Q000235:genetics*; D001161:Arteriosclerosis / Q000235:genetics*; D020022:Genetic Predisposition to Disease; D051379:Mice; D010958:Plasminogen / Q000172:deficiency / Q000235:genetics*; D017395:Plasminogen Activator Inhibitor 1 / Q000378:metabolism; D014568:Urokinase-Type Plasminogen Activator / Q000378:metabolism; D014652:Vascular Diseases / Q000235:genetics / Q000473:pathology*
D001057:Apolipoproteins E; D017395:Plasminogen Activator Inhibitor 1; D010958:Plasminogen; D014568:Urokinase-Type Plasminogen Activator